These markers, while often highly significant and reproducible, generally involve rare alleles, and therefore the clinical utility of the pharmacogenetic biomarkers is limited by a low positive predictive value.
1
—
—
These markers, while often highly significant and reproducible, generally involve rare alleles, and therefore the clinical utility of the pharmacogenetic biomarkers is limited by a low positive predictive value.